Locus Biosciences: Funding, Investors & Team (Sep 2026)
Locus Biosciences is a company that has developed a precision antibacterial platform using CRISPR technology, with the aim of completely transforming how bacterial diseases are treated. By merging the potent antibacterial capabilities of CRISPR-Cas3 with the effective and safe delivery of bacteriophages (bacterial viruses), the platform allows doctors to initiate treatment faster, ultimately leading to improved medical results.
Locus Biosciences has raised $94.4M across 4 funding rounds on record, the most recent an undisclosed round of $23.9M announced in Jan 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Locus Biosciences Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Locus Biosciences Funding Rounds
Locus Biosciences raised $25.0M in a Debt Financing announced in Oct 2021.
4 months later, an undisclosed round of $10.5M was announced in Feb 2022.
3 months later, a Series B of $35.0M was announced in May 2022.
1.7 years later, an undisclosed round of $23.9M was announced in Jan 2024.
Locus Biosciences Founders and Leadership Team
Contact details for the Locus Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Locus Biosciences Funding Compared to Other Biotechnology Startups
Locus Biosciences' latest round of $23.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Locus Biosciences in Biotechnology and Morrisville
Companies Similar to Locus Biosciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Locus Biosciences Funding FAQs
What does Locus Biosciences do?
Locus Biosciences is a company that has developed a precision antibacterial platform using CRISPR technology, with the aim of completely transforming how bacterial diseases are treated. By merging the potent antibacterial capabilities of CRISPR-Cas3 with the effective and safe delivery of bacteriophages (bacterial viruses), the platform allows doctors to initiate treatment faster, ultimately leading to improved medical results.
How much funding has Locus Biosciences raised?
Locus Biosciences has raised $94.4M across 4 rounds on record. The most recent is an undisclosed round of $23.9M announced in Jan 2024.
When did Locus Biosciences last raise funding?
Locus Biosciences' most recent funding round on record is an undisclosed round of $23.9M, announced in Jan 2024.
Who is the CEO of Locus Biosciences?
Paul Garofolo is listed as CEO at Locus Biosciences.
Where is Locus Biosciences headquartered?
Locus Biosciences is based in Morrisville, North Carolina, United States.
How many employees does Locus Biosciences have?
Locus Biosciences is in the 51-100 employee band.
How does Locus Biosciences' funding compare to other Biotechnology startups?
Locus Biosciences' latest round of $23.9M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Locus Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Locus Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.